Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK). ADMET DMPK [Internet]. 2017 Mar. 24 [cited 2026 Jun. 7];5(1):1-8. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/352